The study’s objective was to determine whether adjuvant nivolumab improves disease-free and overall survival among patients with resected non–small cell lung cancer (NSCLC) who completed standard adjuvant chemotherapy or radiotherapy.
Want to stay in touch with the latest updates from JAMA Current Issue? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on Specificfeeds.
Reading your RSS feed has never been easier!
Website title: JAMA Network | Home of JAMA and the Specialty Journals of the American Medical Association